share_log

荣昌生物(688331.SH)拟定增募资不超25.5亿元 用于新药研发项目

Rongchang Biotech (688331.SH) plans to raise no more than 2.55 billion yuan for new drug research and development projects

Zhitong Finance ·  Mar 29 10:37

Rongchang Biotech (688331.SH) disclosed plans to issue A-shares to specific targets in 2024. This time to Te...

According to Zhitong Finance App News, Rongchang Biotech (688331.SH) disclosed plans to issue A-shares to specific targets in 2024. The current issuance target of shares to specific targets is no more than 35 (inclusive) of specific investors. The total amount of capital raised by issuing shares to specific targets is no more than 2.55 billion yuan (inclusive). The total amount of capital raised after deducting the relevant issuance costs will be used for new drug research and development projects.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment